Company profile
Welsis Corp.
OTC: WLSS · Healthcare · Medical - Healthcare Information Services
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
20DFH 3DQ 48GM —SS 14
v0.1 · 55/100 weight · provisional
↑ filing timeliness, market scale · ↓ workforce scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$60.7k
Employees
1
as of 2026-08-02
Market cap
$1.7M
as of 2026-08-02
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02025
Net income-$60.7k-$60.7k2025
Operating income-$50.6k-$50.6k2025
Total assets$2.2k$2.2k2025
Liabilities$152.5k$152.5k2025
Equity-$150.3k-$150.3k2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Welsis Corp.’s revenue?
Welsis Corp. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Dakshidin Corporation31DDecoy Therapeutics Inc.31DProtagenic Therapeutics, Inc.——Azitra, Inc.29DAcro Biomedical Co., Ltd.17DCity View Green Holdings Inc.——Neighbors
Philadelphia →Key facts
CEOBoon Kit Kwok
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersPhiladelphia, PA
ExchangeOTC: WLSS
Employees1
IPO date2024-05-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.